When you seek an injunction and the court denies it, the court may compel the infringer to pay royalties, effectively creating a de‑facto compulsory licence. The four‑factor test—injury, inadequate damages, hardship balance, public‑interest check—determines the rate and auditability. Statutory licences under 28 U.S.C. § 1498 or Bayh‑Dole are narrower, limited to federal use. To secure a stronger remedy, consider negotiating FRAND terms or establishing production evidence early. You’ll find guidance on selecting an ideal strategy and robust for you today.

Key Takeaways

• When courts deny a preliminary injunction, they may award periodic royalty payments, effectively creating a de‑facto compulsory license to the patentee.
• The royalty rate is set by the judge and changed only if material facts change, with mandatory record‑keeping for audit.
• Courts still permit infringers to sell the patented product while remitting royalties, mitigating market shutdown for the patentee.
• Denial typically occurs when the four‑factor irreparability test fails: insufficient irreparable injury, inadequate damages, unfavorable hardship balance, or public‑interest concerns.
• Unlike statutory compulsory licences (§1498, Bayh‑Dole), judicially imposed royalties apply universally, with compensation determined case‑by‑case rather than a preset statutory schedule.

What Does eBay V. Mercexchange Mean for Patent Owners?

Because the Supreme Court’s decision in *eBay Inc. v. MercExchange Ltd. & 2d 193 calls out the Federal Circuit’s blanket injunction rule, you must rethink your enforcement strategy. The ruling removed the presumption that infringement automatically yields irreparable harm, a doctrine that let patent owners parlay almost every infringement into a permanent restraining order. Now every injunction petition requires proof across four factors: actual injury, inadequacy of damages, a balanced hardship assessment, and a public‑interest check. Consequently, industry impact is significant: non‑practicing entities and PAEs will routinely face denials, while competitors retain a higher success rate. Litigation costs rise, as defendants may contest irreparability claims. Your portfolio strategy should shift toward demand for lump‑sum claims or ongoing royalties when injunctions are untenable. Public utilities and tech firms must monitor court tendencies, using the four‑factor framework to gauge when an injunction is likely or when alternative remedies will prevail.

Additionally, the Supreme Court explicitly required litigants to examine each of the four prongs—irreparable injury, inadequate damages, balance of hardships, and public interest—separately, a shift from the earlier blanket approach.

What Factors Prompt Courts to Grant Compulsory Patent Licences?

When the court weighs the exigency of public health, unmet supply, and antitrust concerns, it may grant a compulsory license to secure broader access. You confront the TRIPS Article 31 framework, which authorizes licensing during national emergencies or when supply deficiency hinders essential treatments. Under the Doha Declaration, the public health imperative overrides exclusive rights if prices or availability prove prohibitive, and COVID‑19 has testily qualified as extreme urgency. If the patent holder fails to meet reasonable demand within a reasonable window—typically three years for Indian, Canadian, or UK patents—circuit courts may require a license to restore adequate supply. Additionally, evidence of antitrust violations—such as refusal to license dependent patents that block competition—strengthens your petition. The court balances irreparable harm against public interest, often awarding rights without injunctive relief to guarantee that essential cures remain accessible. The case will rest on the statutory basis and the demonstrated community benefit to win. Such a license will require owner compensation to the patent holder.

Step‑by‑Step: Applying the Four‑Factor Equity Test

The first factor you assess is irreparable injury. You must show harm beyond monetary compensation, per eBay v. MercExchange, and demonstrate that market loss or unique competitive injury cannot be remedied by damages. Evidence gathering is essential for establishing the irreparability claim.

1. Identify the specific injury and quantify loss.
2. Collect data where competitiveness is compromised.
3. Compare with precedent review for similar cases.
4. Prepare expert testimony to corroborate irreparable harm.

The second factor, inadequacy of legal remedies, requires you to prove damages cannot fully compensate. Your precedent review must confirm that licensing or monetary relief is insufficient. Research shows the courts historically granted permanent injunctions in 91.2 % of patent infringement cases, underscoring the significance of irreparable injury, a trend rooted in the historical injunction rate. The third factor asks you to balance hardships, weighing your benefits against the defendant’s investment. The fourth factor mandates a public interest check, ensuring the injunction doesn’t impair innovation or access. Apply each step methodically; courts review the four‑factor test for abuse, insisting compliance before granting an injunction.

What Happens When Courts Deny Injunctions?

If a court denies an injunction, it bars the patentee from preventing the infringer’s continued sale of the product under the patent. You then face de‑facto compulsory licensing: the infringer keeps manufacturing while paying court‑ordered royalties. This shifts the market, reducing potential disruption and allowing competitors to launch similar products. You must prove irreparable harm linked directly to infringement—price erosion, goodwill loss, reputational damage. Without that causal nexus, the court sees equitable relief unnecessary. Standard‑essential patents encounter extra scrutiny; FRAND commitments often preclude injunctions unless royalties are unreasonable or negotiations stall. The table below illustrates key outcomes and their effects.

In each case, you’ll receive either a permanent injunction or a royalty schedule. The denial forces you negotiate, triggering a competitive response that may erode market share.

Courts may deny an injunction when the patentee’s claimed harm is grossly disproportionate or would harm public interest.

How Do Court‑Ordered Royalties Convert to Compulsory Licences?

Because courts deny injunctions, they may instead impose ongoing royalty payments, thereby functioning as de‑facto compulsory licenses that obligate the infringer to pay for continuous practice of the patented technology. In Russia, Vertex’s official distributor Sanofi Russia JSC faced a compulsory licence claim filed by a Medical Research Company. You rely on a court‑ordered royalty as a de‑facto mandated licensing vehicle. The judge determines entry‑level rates, then you calculate future obligations via royalty optimization models, each payment covering use of the title’s protected steps while respecting your existing market structure.

When courts deny injunctions, they enforce de‑facto compulsory licensing through judge‑set ongoing royalties and optimization calculations.

1. The patent’s exploring statute collapses post‑injunction denial, forming a de‑facto exclusive right for the infringer.
2. The court fixes a periodic rate that mirrors an equitable mandate, creating an ongoing licensing obligation.
3. Adjustments arise only if material fact changes, preserving the fairness of royalty optimization.
4. Record retention is mandatory, ensuring auditability of the mandated licensing terms. Therefore, your compliance with these royalty payments preserves a de‑facto licensing regime that balances protection and access.

Do 28 USC 1498 and Bayh‑Dole Provide Compulsory Licences?

While 28 U.S.C. § 1498 unconditionally permits the federal government to use any patented invention without a prior license, Bayh‑Dole’s march‑in provisions selectively empower agencies to compel licensing under a narrow set of circumstances. In practice, courts have interpreted the phrase “entire” in § 1498 as not extending to the patentee’s profits, limiting the scope to actual costs rather than full market value. You rely on these statutes as distinct statutory bases for federal licensing. § 1498 allows immediate use; the patentee’s exclusive remedy is an action for reasonable compensation before the Court of Federal Claims. No injunction bars use, establishing an automatic compulsory license. Bayh‑Dole, by contrast, requires a proactive agency decision that a subject invention remains unused, inadequately available, or threatens national security. The agency then may license, offering only a “reasonable” royalty schedule. Both mechanisms demand proof of federal involvement; private entities cannot invoke them. Consequently, the legal landscape favors negotiated settlements, while both statutes exist as dormant tools constrained by narrow application criteria. Accordingly, you should recognize that enforcement of these statutory bases requires meticulous documentation.

Which Remedy Is Stronger: Statutory or Judicial Compulsory Licences?

Although statutory regulations grant the government specific compulsory licences in tightly circumscribed domains, the patentee’s recourse is limited to government‑initiated actions with predetermined remedies. Under the Paris Convention, the United States must permit compulsory licenses as part of its international commitments. When you assess remedy strength, Statutory Weight favors narrow, enforceable gaps covered by 28 USC §1498, Bayh‑Dole, or the Atomic Energy Act. Conversely, Judicial Reach affords courts discretionary power to deny injunctions, converting a infringement case into a temporary compulsory license, and to impose post‑infringement damages. The comparison hinges on enforcement certainty, scope, and compensation. Consider the following points:

Statutory licences impose narrow, agency‑administered remedies; judicial options offer broader, discretionary enforcement and post‑infringement damages.

1. Coverage breadth: statutory licences target defined sectors, while judicial licences apply across all infringement disputes.
2. Enforcement certainty: statutory licences enforce via agency action, judicial licences subject to appeal and interlocutory relief.
3. Compensation: statutory sets reasonable royalty; judicial imposes damages post‑infringement, possibly augmented for willfulness.
4. Adaptability: statutory weight is rigid, whereas judicial reach can adjust based on equitable factors and public interest.

How Can Patent Owners Avoid Unwanted Compulsory Licences?

When you weigh the relative force of statutory and judicial compulsory‑license regimes, the natural step is to strengthen your patent’s resistance to any unwanted compulsory‑licence claim. Recent debates highlight how patent waivers are marketed as a moral necessity. First, you’ve conducted Strategic Negotiations with potential licensees, offering voluntary FRAND terms before a court can compel. By publishing availability statements, you satisfy the “unsuccessful endeavour” duty of TRIPS and preclude unjustified claims. Second, you’ve maintained Expedient Production: manufacture and market within the required window—typically three years in India—while recording volumes, pricing, and market penetration. This evidentiary trail counters non‑working allegations. Third, you file non‑working affidavits and oppose applications early, citing active exploitation and futile previous negotiations. Fourth, stay compliant with antitrust rules; show that no legitimate competitive harm results from refusing a licence. Finally, you’ve structured licences with royalties, milestones, and supply agreements to deter requests for compulsory licences while preserving market control. These measures safeguard your exclusivity against compulsory claims.

Frequently Asked Questions

Are There Limits on Compulsory Licensing Fees?

Yes, there’s a limit on compulsory licensing fees. Federal statutes cap fees at a percentage of net sales, generally 5% per Article 146 in domestic cases and not exceeding 4% of total price for imports. These fee caps create royalty caps that must align with the invention’s economic value, remaining term, and contract price. Courts enforce these limits, ensuring your compensation stays within statutory bounds and complies with TRIPS standards.

Can Patentees Sue for Damages Post‑Licence?

Like a lighthouse in a storm, a court’s denial lights your path. Yes, you can sue for damages beyond the royalty benefit, within the damages scope of the license. The court’s injunction denial typically orders you to pay a reasonable royalty for future infringement, but it doesn’t bar you from seeking damages for injury loss incurred before or after that threshold. Include any lost profits or unjust enrichment today immediately.

Do Compulsory Licences Persist Beyond Patent Life?

No, you cannot rely on a compulsory licence beyond the patent’s term. The licence validity concludes automatically when the patent expires, and the licence scope remains confined to the period. Courts enforce the expiry regardless of ongoing use. Once the patent life ends, both royalty obligations and enforcement rights vanish, and you must cease using the licensed technology unless a new licence is granted in same jurisdiction by the court.

Can Courts Mandate Royalties After Patent Invalidation?

Yes, you can hit the nail on the head by having courts impose a Royalty Scale even after a patent’s invalidation. When a breach of litigation leads to invalidity, you retain the right to seek ongoing payments. The four‑factor equity test remains applicable, ensuring irreparable harm is assessed independently. Consequently, a post‑invalidity royalty order can enforce compensation, upholding your legitimate interests while preserving the balance between parties fairly for continuously.

What Jurisdictions Enforce Compulsory Licensing Uniformly?

You’re in luck: the EU Framework and India’s Statute offer the most uniform compulsory licensing regimes. Both systems set clear statutory triggers, mandatory notice, and statutory remuneration. Under the EU, Article 31(B) provides a single, harmonised procedure across Member States. India’s Section 84(1) grants licences after three years of non‑use or unmet public need, with courts enforcing royalty ceilings. These frameworks guarantee predictable, nationwide application. They’re regarded as benchmark models for policy.

Conclusion

You navigate the patent landscape by keeping your rights clamped like a tight seal. When courts refuse injunctions, they drizzle statutory licensing onto your claims, turning rigid bars into rivers of royalties. In this tide, you’ll chase clarity today: align your strategy with the four‑factor test, preemptively adjust licensing terms, and stay ready to argue with precision. Stay vigilant; shape the future of your IP. Before the next hearing, calmly calibrate your stance and onward.

James Bateson

Lawyer